课题基金 / 基金详情

PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947.

PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947.
第一阶段可卡因药物相互作用研究。
批准号：
10937276
负责人：
DANIEL MOLINA
金额：
$20.23万
依托单位：
TECHNICAL RESOURCES INTERNATIONAL, INC.
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
项目状态：
未结题
起止时间：
2023-08-10 至 2025-02-09
来源：
https://reporter.nih.gov/project-details/10937276
关键词：
CocaineDrug InteractionsDrug KineticsNational Institute of Drug AbusePhaseResources

项目摘要

项目成果

DANIEL MOLINA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PHARMACOKINETIC ANALYSIS RESOURCE CENTER (TRI) The purpose of this order is to provide clinical support for a Phase 1 clinical pharmacokinetic trial of an investigational agent aimed at treating cocaine abuse. This contract will provide medical writing, data management support, site monitoring, statistical analysis and pharmacokinetic analyses as well as study record management and archiving.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FY23. TO5. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 01/18/2022 - 04/16/2024. NIDA REF. NO. N01DA-19-8947.
NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC)
DATA COORDINATING CENTER FOR SPROUTS AGES 6- AND 7- YEARS ASSESSMENTS AND STUDY CLOSEOUT
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE OTHER SUPPORT SERVICES TO NIDA AS PART OF CONTRACT PERFORMANCE. SPECIFICALLY, THIS TO INVOLVES WORK DESCRIBED IN TASK G. THE SCOPE OF THIS TASK IS FOR SEV
海外基金